Key result
Double Flash Spiral CCTA achieves ~96% diagnostic image quality in AF patients at low radiation.
Observational (n=28)
Answers are grounded in this paper and cite their sources.
OBJECTIVE: The diagnosis of coronary artery disease (CAD) in atrial fibrillation (AF) patients using coronary computed tomography angiography (CCTA) requires a large exposure dosage or repeated examinations. This study evaluates the feasibility of using low-dose CCTA in the double prospectively ECG-triggered high-pitch spiral acquisition mode (Double Flash Spiral mode). METHODS: Twenty-eight AF patients with suspected CAD were recruited. Double Flash Spiral mode (tube voltage 100 kVp) and iterative reconstruction was used for CCTA examination. Two radiologists cross-evaluated the CCTA image quality. The effective radiation dose was measured for each patient. RESULTS: ) were recruited and 337 artery segments were evaluated. In total, 98.5% (332/337) of the coronary artery segments and 96.4% (27/28) of the AF patients were rated as diagnostically evaluable. Of these 27 diagnosable patients, 17 patients (63%) were diagnosed with multi-vessel stenosis. Besides, 5 of 28 patients (17.9%) have left atrial appendage thrombus. The quality of the integrated image was significantly better than either of the individual first or the second scans, based on segments (P < 0.001) and patients (P < 0.05). The mean effective radiation dose was 1.5 mSv ±0.4 mSv. CONCLUSIONS: Using the Double Flash Spiral mode at low radiation dose (mean 1.5 mSv), 98.5% of the coronary segments and 96.4% of the scans were of sufficient diagnostic quality.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2017) conducted an observational in Atrial fibrillation with suspected coronary artery disease (n=28). Low-dose CCTA in Double Flash Spiral mode vs. Individual first or second scans was evaluated on Diagnostic evaluability of coronary artery segments and patients (p=<0.05). Low-dose CCTA using Double Flash Spiral mode achieved diagnostic image quality in 96.4% of AF patients and 98.5% of coronary segments at a mean dose of 1.5 mSv.
Synapse has enriched 10 related papers. Consider them for comparative context: